[Department of Error] Department of Error
Kendler DL, Marin F, Zerbini CAF, et al. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet 2018; 391: 230–40—The results section of this Article should have stated that 1013 (74·2%) of 1366 enrolled patients completed the trial. This correction has been made to the online version as of Nov 29, 2018.